Serinol

We are Serinol CAS:534-03-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Product Name: Serinol
Synonym: 2-Amino-1,3-propanediol
Cas No.: 534-03-2
Formula: C3H9NO2
MW: 91.11
EINECS No.: 208-584-0

Density: 1.2±0.1 g/cm3
Boiling point: 266.7±20.0 °C at 760 mmHg
Melting point: 52-55 °C(lit.)
Flash point: 115.1±21.8 °C
Refractive index: 1.496

HS Code: 2922199090
/13%
UN No.: 3259
Hazard class: 8 categories 
Packing level: Class III
 
Specification

Appearance: White crystalline solid
Assay: ≥99%
Water: ≤0.50%
Unspecified impurity: ≤0.50%
 

Application
Intermediate of Iopamidol and Voglibose.
Be used as pharmaceutical raw materials.
2-Aminopropane-1,3-diol is used in the synthesis of novel potent inhibitors of human uridine phosphorylase used to reduce toxicity of 5-fluorouracil without affecting its antitumor activity.
 
Packaging
25 kg/barrel, can also be packaged according to customer requirements. 
 
Storage
Store in a cool, ventilated warehouse. 
Keep away from fire and heat. 
The temperature should not exceed 37 °C. 

Serinol


Related News: The program caused the price of some drugs to plunge more than 90% when it was introduced last year in some cities, state news agency Xinhua said.(1R) -2- [2- (4-nitrofenil) etilamino] -1-feniletanol CAS:223673-34-5 The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth.Glycyrrhizic Acid Dipotassium Salt Hydrate CAS:68797-35-3 The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth.2,6-Difluorobenzoyl isocyanate CAS:60731-73-9 “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.

Related Products
Product Name
1-Benzylimidazole View Details
4-Bromotriphenylamine View Details
Chlorphenesin View Details
4-methoxy-2-oxo-1H-pyridine-3-carbonitrile manufacturer ethyl 3-chlorosulfonyl-1-methylpyrazole-4-carboxylate manufacturer 1-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-2-chloro-Ethanone manufacturer 4-bromopyridine-2-carboxylic acid manufacturer Methyl chloroacetate manufacturer